Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review.

Journal of drugs in dermatology : JDD - 1 Dec 2023

Mirza Verda S, Zaino Mallory L, Feldman Steven R

Abstract excerpt

BACKGROUND: Candida albicans is an opportunistic pathogenic yeast commensal in human mucosa. In individuals with compromised immune systems, it can present as chronic mucocutaneous candidiasis (CMC) or systemic infection. CMC often exists in the presence of other infectious phenotypes due to dysfunction of the Th17 immune response. OBJECTIVE: To examine innate error immunities (IEI) of the Th17 immune response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Candida albicans
Share to Candidiasis, Chronic Mucocutaneous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunity, Innate

Share to Interleukin-17

Share to Mutation

Source

Identifiers

PMID: 38051840
DOI: 10.36849/JDD.7579

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review.PMID 38051840Read ↗

Chronic mucocutaneous candidiasis disease associated with inborn errors of IL‐17 immunitySemantic proximity Read ↗

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.Semantic proximity Read ↗

Chronic Mucocutaneous Candidiasis in Early Life: Insights Into Immune Mechanisms and Novel Targeted Therapies.Semantic proximity Read ↗

Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.Semantic proximity Read ↗

Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasisSemantic proximity Read ↗

TH17 deficiency in human disease.Semantic proximity Read ↗

Human inborn errors of immunity underlying superficial or invasive candidiasis.Semantic proximity Read ↗

Interleukin 17-Mediated Host Defense against Candida albicansSemantic proximity Read ↗

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.Semantic proximity Read ↗

The Th17/IL-17 Axis and Host Defense Against Fungal InfectionsSemantic proximity Read ↗

A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis.Semantic proximity Read ↗

Biological and clinical significance of T helper 17 cell deficiency: insight into monogenic defects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.